Literature DB >> 21084594

Phosphorylation dynamics regulate Hsp27-mediated rescue of neuronal plasticity deficits in tau transgenic mice.

Jose F Abisambra1, Laura J Blair, Shannon E Hill, Jeffrey R Jones, Clara Kraft, Justin Rogers, John Koren, Umesh K Jinwal, Lisa Lawson, Amelia G Johnson, Donna Wilcock, John C O'Leary, Karen Jansen-West, Martin Muschol, Todd E Golde, Edwin J Weeber, Jessica Banko, Chad A Dickey.   

Abstract

Molecular chaperones regulate the aggregation of a number of proteins that pathologically misfold and accumulate in neurodegenerative diseases. Identifying ways to manipulate these proteins in disease models is an area of intense investigation; however, the translation of these results to the mammalian brain has progressed more slowly. In this study, we investigated the ability of one of these chaperones, heat shock protein 27 (Hsp27), to modulate tau dynamics. Recombinant wild-type Hsp27 and a genetically altered version of Hsp27 that is perpetually pseudo-phosphorylated (3×S/D) were generated. Both Hsp27 variants interacted with tau, and atomic force microscopy and dynamic light scattering showed that both variants also prevented tau filament formation. However, extrinsic genetic delivery of these two Hsp27 variants to tau transgenic mice using adeno-associated viral particles showed that wild-type Hsp27 reduced neuronal tau levels, whereas 3×S/D Hsp27 was associated with increased tau levels. Moreover, rapid decay in hippocampal long-term potentiation (LTP) intrinsic to this tau transgenic model was rescued by wild-type Hsp27 overexpression but not by 3×S/D Hsp27. Because the 3×S/D Hsp27 mutant cannot cycle between phosphorylated and dephosphorylated states, we can conclude that Hsp27 must be functionally dynamic to facilitate tau clearance from the brain and rescue LTP; however, when this property is compromised, Hsp27 may actually facilitate accumulation of soluble tau intermediates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084594      PMCID: PMC3073547          DOI: 10.1523/JNEUROSCI.3155-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

2.  Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).

Authors:  Martin Ramsden; Linda Kotilinek; Colleen Forster; Jennifer Paulson; Eileen McGowan; Karen SantaCruz; Aaron Guimaraes; Mei Yue; Jada Lewis; George Carlson; Michael Hutton; Karen H Ashe
Journal:  J Neurosci       Date:  2005-11-16       Impact factor: 6.167

3.  p38 kinase is activated in the Alzheimer's disease brain.

Authors:  K Hensley; R A Floyd; N Y Zheng; R Nael; K A Robinson; X Nguyen; Q N Pye; C A Stewart; J Geddes; W R Markesbery; E Patel; G V Johnson; G Bing
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

4.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

5.  Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins.

Authors:  D Stokoe; K Engel; D G Campbell; P Cohen; M Gaestel
Journal:  FEBS Lett       Date:  1992-11-30       Impact factor: 4.124

6.  Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging.

Authors:  Anat Ben-Zvi; Elizabeth A Miller; Richard I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

7.  Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein.

Authors:  J Huot; G Roy; H Lambert; P Chrétien; J Landry
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

8.  Axotomy abolishes NeuN expression in facial but not rubrospinal neurons.

Authors:  Lowell T McPhail; Christopher B McBride; John McGraw; John D Steeves; Wolfram Tetzlaff
Journal:  Exp Neurol       Date:  2004-01       Impact factor: 5.330

Review 9.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

10.  Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection.

Authors:  Ehud Cohen; Deguo Du; Derek Joyce; Erik A Kapernick; Yuli Volovik; Jeffery W Kelly; Andrew Dillin
Journal:  Aging Cell       Date:  2009-12-11       Impact factor: 9.304

View more
  60 in total

1.  Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.

Authors:  Laura J Blair; Bryce A Nordhues; Shannon E Hill; K Matthew Scaglione; John C O'Leary; Sarah N Fontaine; Leonid Breydo; Bo Zhang; Pengfei Li; Li Wang; Carl Cotman; Henry L Paulson; Martin Muschol; Vladimir N Uversky; Torsten Klengel; Elisabeth B Binder; Rakez Kayed; Todd E Golde; Nicole Berchtold; Chad A Dickey
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network.

Authors:  Anan Yu; Susan G Fox; Annalisa Cavallini; Caroline Kerridge; Michael J O'Neill; Joanna Wolak; Suchira Bose; Richard I Morimoto
Journal:  J Biol Chem       Date:  2019-04-01       Impact factor: 5.157

Review 3.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

Review 4.  Therapeutic Strategies for Restoring Tau Homeostasis.

Authors:  Zapporah T Young; Sue Ann Mok; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

Review 5.  Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.

Authors:  Yoshinari Miyata; John Koren; Janine Kiray; Chad A Dickey; Jason E Gestwicki
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

Review 6.  Molecular chaperones in the brain endothelial barrier: neurotoxicity or neuroprotection?

Authors:  Dominique Thuringer; Carmen Garrido
Journal:  FASEB J       Date:  2019-07-26       Impact factor: 5.191

7.  Mechanistic insights into the switch of αB-crystallin chaperone activity and self-multimerization.

Authors:  Zhenying Liu; Chuchu Wang; Yichen Li; Chunyu Zhao; Tongzhou Li; Dan Li; Shengnan Zhang; Cong Liu
Journal:  J Biol Chem       Date:  2018-08-03       Impact factor: 5.157

8.  Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism.

Authors:  Amirthaa Suntharalingam; Jose F Abisambra; John C O'Leary; John Koren; Bo Zhang; Myung Kuk Joe; Laura J Blair; Shannon E Hill; Umesh K Jinwal; Matthew Cockman; Adam S Duerfeldt; Stanislav Tomarev; Brian S J Blagg; Raquel L Lieberman; Chad A Dickey
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

Review 9.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation.

Authors:  Jose F Abisambra; Umesh K Jinwal; Laura J Blair; John C O'Leary; Qingyou Li; Sarah Brady; Li Wang; Chantal E Guidi; Bo Zhang; Bryce A Nordhues; Matthew Cockman; Amirthaa Suntharalingham; Pengfei Li; Ying Jin; Christopher A Atkins; Chad A Dickey
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.